CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers
Authors:
- 1 May 1997
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 25 (2) , 123-129
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Changes in Interleukin-1β and Soluble Interleukin-2 Receptor Levels in CSF and Serum of Schizophrenic PatientsJournal of Basic and Clinical Physiology and Pharmacology, 1995
- Interleukin‐2 Modulates Evoked Release of [3H]Dopamine in Rat Cultured Mesencephalic CellsJournal of Neurochemistry, 1993
- Interleukin‐2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brainJournal of Neuroscience Research, 1993
- Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjectsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1993
- Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenicsSchizophrenia Research, 1990
- Morphometry of the corpus callosum in monozygotic twins discordant for schizophrenia: a magnetic resonance imaging study.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Decreased interleukin-2 production in schizophrenic patientsBiological Psychiatry, 1989
- The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1987
- Clinical and Laboratory Evidence of Autoimmunity in Acute SchizophreniaAnnals of the New York Academy of Sciences, 1987
- Interleukin 1: An Immunological PerspectiveAnnual Review of Immunology, 1985